And we’re bringing these industry leaders—and many, many more—to you LIVE during BIO Digital, which takes place June 8-12, 2020. Here’s the scoop on the latest heavy hitters confirmed to speak during our virtual convention.
We’ve confirmed Dr. Anthony Fauci and Dr. Moncef Slaoui as headline speakers during BIO Digital,our virtual convention taking place June 8-12, 2020 from the comfort of your laptop or mobile device.
The details:
- Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), will join an intimate fireside chat with BIO’s incoming CEO, Dr. Michelle McMurry-Heath, to discuss the science emerging in this crisis.
- Dr. Moncef Slaoui, Head of U.S. Operation Warp Speed, will talk about what it will take to develop a COVID-19 vaccine—and deliver billions of doses around the world. He’ll be joined by speakers from the Coalition for Epidemic Preparedness Innovation (CEPI), The GAVI Alliance, Merck, and Moderna.
They’re part of a three-part plenary on vaccine development sponsored by Johnson & Johnson. The plenary will also feature the Duke Margolis Center for Health Policy, the FDA Center for Biologics Evaluation and Research, Novavax, and BIO’s own Phyllis Arthur.
It’s 1 of 50 live and interactive sessions to bring you the latest news on COVID-19 vaccines and therapies, emerging science straight from the labs, and the pandemic’s impact on global health systems, investment, and policy.
Yes, Hahn and Bancel will be there, too. FDA Commissioner Stephen Hahn, Moderna CEO Stéphane Bancel, and Merck Chief Patient Officer and former CDC Director Dr. Julie Gerberding are just a few more of the leaders on the agenda.
But that’s not all!Register for BIO Digital and you’ll also get access to 60 on-demand sessions, 250 company presentations, and virtual One-on-One Partnering in a 24-hour global time zone format.
Our new CEO previews her discussion with Dr. Fauci: “All of America has come to know what those of us in public health have known for decades: He is an unwavering advocate for patients and is critical for helping the country navigate this unprecedented challenge,” says Dr. Michelle McMurry-Heath in a new video clip. “I will ask him where the science is right now, what are realistic expectations for a vaccine, what are his expectations for our industry, and what policy decisions might influence our success or our failure. It will be an exciting discussion, and I hope you will join us.”
